Bevacizumab Intravenous and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Bevacizumab Intravenous and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Insulin degludec Subcutaneous
- Bevacizumab Intravenous-Insulin detemir
- Bevacizumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Bevacizumab Intravenous-Insulin Detemir (Vials)
- Bevacizumab Intravenous-Insulin detemir Subcutaneous
- Bevacizumab Intravenous-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Bevacizumab-awwb
- Insulin degludec and liraglutide Subcutaneous-Bevacizumab-awwb Intravenous
- Insulin degludec and liraglutide Subcutaneous-Bevespi Aerosphere
- Insulin degludec and liraglutide Subcutaneous-Bevyxxa
- Insulin degludec and liraglutide Subcutaneous-Bexarotene
- Insulin degludec and liraglutide Subcutaneous-Bexarotene (Systemic)